Skip to main content
Log in

Lipid screening well worth it in Hodgkin's survivors

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Chen AB, Punglia RS, Kuntz KM, Mauch PM, Ng AK.Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. Journal of Clinical Oncology 27: 5383-5389, No. 32, 14 Sep 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipid screening well worth it in Hodgkin's survivors. Pharmacoecon. Outcomes News 588, 7 (2009). https://doi.org/10.2165/00151234-200905880-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00012

Keywords

Navigation